@FiercePharma: What we talk about when we talk about pharma. Commentary | Join our LinkedIn group | Follow @FiercePharma
@EricPFierce: Who manufacturers the top selling diabetes treatments? Novo has 5 of top 10 but not the top two. Special report | Follow @EricPFierce
> A federal judge said Novartis ($NVS) has to face whistleblower claims that it promoted off-label use, some of it known to be harmful, of its atopic dermatitis drug Elidel. Report
> The cost of specialty drugs will boost healthcare spending in the coming years, offsetting the savings from a dwindling supply of new generic launches, PricewaterhouseCoopers says. Report
> Pfizer ($PFE) is offering shareholders a 5% premium to exchange their stock for shares of its animal health company Zoetis as the drugmaker spins off its remaining stake. Report
> The Department of Health and Human Services Inspector General said Medicare should do more to investigate doctors who prescribe drugs in potentially questionable or harmful ways. Report
> Cases of the cancer-causing human papillomavirus (HPV) have plunged in girls and young women since Merck's ($MRK) Gardasil vaccine launched in 2006, a study found. Report
> A U.S. court determined that India's Zydus Cadila stepped on Takeda's patent for the drug Prevacid SoluTab. Report
@FierceMedDev: Wright selling off hip and knee biz for $290M. Report | Follow @FierceMedDev
@DamianFierce: Japan's Terumo is adding 400+ jobs in an Irish R&D expansion. Yesterday's story | Follow @DamianFierce
@MichaelGFierce: Biosensor nanoparticles deliver cancer drug with precise, 3-D imaging. More | Follow @MichaelGFierce
> Brainsway partners up to push anti-depression tech in U.S. Article
> Mayo joins Sanovas to develop lung-clearing asthma treatment. Story
> Atossa teams with Thermo to market 'Pap smear for breast cancer.' News
Biotech News
@FierceBiotech: ICYMI this week's Industry Voices column - Ichorcumab: the blood of the gods? Feature | Follow @FierceBiotech
@JohnCFierce: Sanofi - in need of some inspiration - partners with Curie Inst. on ovarian cancer targets. Release | Follow @JohnCFierce
@RyanMFierce: After Sanofi winds down manufacturing in Dagenham, U.K., what are the chances of a vibrant startup scene emerging there? More | Follow @RyanMFierce
@EmilyMFierce: Biopharma tweeps, connect with colleagues and the editors of @FierceBiotech by joining our new LinkedIn group. | Follow @EmilyMFierce
> Cardio3 targets big cardio-drug market with small IPO. Item
> Biotech M&A buzz: Forest, others weigh offers for Elan. More
> PTC overcomes repeated setbacks to raise $125M in IPO. Report
> GlaxoSmithKline fuels VC fund as part of rare diseases blitz. Article
Vaccines News
> CDC finds vaccines halved HPV infections in teenage girls. Report
> GSK's rotavirus vaccine as effective as Merck shot. Item
> Tax loophole eyed ahead of launch of Sanofi, GSK, AstraZeneca quadrivalent shots. More
> HPV vaccine pioneer targeting skin cancer jab. Story
> Japan withdraws recommendation of Merck and GSK HPV jabs. Article
> CDC readies for 4-in-1 flu vaccines. More
Pharma Manufacturing News
> GSK, Pfizer help start effort researching manufacturing innovations. Story
> Brazil to build Protalix a plant as part of sophisticated tech transfer. News
> Sanofi plant in London set to close by end of month. Article
> Gilead recalls 20 batches of AmBisome due to possible contamination. Report
And Finally... A respiratory virus that recently emerged in Saudi Arabia spread with chiling ease to ill patients in the hospital, an investigation found. Report